Chief Executive Officer, Emmer Capital Partners Limited

Manishi Raychaudhuri

Chief Executive Officer

Emmer Capital Partners Limited

Emmer Capital Partners is an Asia Pacific focused financial advisory firm engaging in strategic financial asset allocation advice, bespoke thematic research and advising early-stage companies and connecting them to investors. Emmer Capital provides macro-economic and multi-asset investment strategy inputs to institutions, family offices, private wealth managers, private equity, and corporate boards directly and through independent research platforms. Emmer Capital also advises a wide range of startup companies on fund raising and business strategy. Emmer Capital's active engagement with the print and electronic media reaches a broad spectrum of investors across the globe.

Cross Asset Strategy

<ul>
<li>The iEdge Singapore Next 50 indices track 50 largest SGX companies beyond the top 30, with minimum S$100m market cap, 15% free float and 6-month median S$100K daily traded value.</li>
<li>The Next 50’s mid-cap constituents offer opportunities for restructuring to unlock value through governance reforms, asset optimization, and capital recycling, narrowing the gap between intrinsic value and public market prices.</li>
<li>Our study of take private offers, spin-offs and asset light transitions among the Next 50 constituents reveals that this index represents the next generation of Singaporean value plays.</li>
</ul>


The iEdge Singapore Next 50 indices track 50 largest SGX companies beyond the top 30, with minimum S$100m market cap, 15% free float and 6-month median S$100K daily traded value.
The Next 50’s mid-cap constituents offer opportunities for restructuring to unlock value through governance reforms, asset optimization, and capital recycling, narrowing the gap between intrinsic value and public market prices.
Our study of take private offers, spin-offs and asset light transitions among the Next 50 constituents reveals that this index represents the next generation of Singaporean value plays.


How Corporate Actions Are Unlocking Mid-Cap Value in the SGX the iEdge Singapore Next 50 Indices

Asia Real Estate News Tracker, Asia Real Estate Tracker

Asia Real Estate Tracker

Asia Real Estate News Tracker

Tracking developments across Asia's regional real estate markets

Thematic (Sector/Industry)

<ul><li>Brookfield is close to acquiring a Sydney office property for $318 million amid APAC real estate growth.</li><li>Macquarie has completed an $8.3 billion acquisition of Qube, a significant player in Australian logistics.</li><li>ESR has divested stakes in a Yokohama warehouse, while Brookfield and GIC target a $2 billion deal.</li></ul>

Brookfield is close to acquiring a Sydney office property for $318 million amid APAC real estate growth.Macquarie has completed an $8.3 billion acquisition of Qube, a significant player in Australian logistics.ESR has divested stakes in a Yokohama warehouse, while Brookfield and GIC target a $2 billion deal.

Asia Real Estate Tracker (17-Feb-2026): Brookfield nears $318M Sydney office deal.

Singapore Market Roundup, Singapore Market Roundup

Singapore Market Roundup

<ul><li>OCBC's Lim increases Boustead Singapore's fair value to $2.45.</li><li>DBS Group and RHB maintain 'buy' on Elite UK REIT after FY2025 results.</li><li>OCBC lowers Sheng Siong to 'hold' while raising target price ahead of FY2025 results.</li></ul>

OCBC's Lim increases Boustead Singapore's fair value to $2.45.DBS Group and RHB maintain 'buy' on Elite UK REIT after FY2025 results.OCBC lowers Sheng Siong to 'hold' while raising target price ahead of FY2025 results.

Singapore Market Roundup (10-Feb-2026): OCBC raises Boustead Singapore's fair value to $2.45.

<ul>
<li>Beansprout rates CSE Global 'buy' with a target price of $1.40.</li>
<li>DBS raises Nam Cheong target price to $1.60, calling it a 'hidden gem.'</li>
<li>CGSI maintains "add" on Genting SG, anticipating gradual earnings growth from 1QFY2026.</li>
</ul>


Beansprout rates CSE Global 'buy' with a target price of $1.40.
DBS raises Nam Cheong target price to $1.60, calling it a 'hidden gem.'
CGSI maintains "add" on Genting SG, anticipating gradual earnings growth from 1QFY2026.


Singapore Market Roundup (30-Jan-2026): CSE Global rated 'buy' by Beansprout, target $1.40.

<ul><li>Seatrium faces 'arbitration noise,' yet CGSI and Citi maintain positive outlooks.</li><li>RHB maintains 'buy' on Raffles Medical Group for potential growth in 2HFY2025.</li><li>CGSI sees strong re-rating potential for Info-Tech Systems after its post-IPO drop.</li></ul>

Seatrium faces 'arbitration noise,' yet CGSI and Citi maintain positive outlooks.RHB maintains 'buy' on Raffles Medical Group for potential growth in 2HFY2025.CGSI sees strong re-rating potential for Info-Tech Systems after its post-IPO drop.

Singapore Market Roundup (23-Jan-2026): Seatrium endures 'arbitration noise' but CGSI and Citi

Singapore

Centurion Corporation Limited is a Singapore-based investment holding company that owns, develops, and manages specialized accommodation assets globally. It provides purpose-built worker accommodation under the "Westlite Accommodation" brand and purpose-built student accommodation under the "Dwell" and "EPIISOD" brands, alongside an optical storage media manufacturing business. The company was established in 1981 and is headquartered in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Centurion (CENT SP)

How Corporate Actions Are Unlocking Mid-Cap Value in the SGX the iEdge Singapore Next 50 Indices

iEdge Singapore Next 50 index offers a prime arena to identify companies that could unlock value through governance reforms & asset optimization,...

Manishi Raychaudhuri

Asia Real Estate Tracker (17-Feb-2026): Brookfield nears $318M Sydney office deal.

Brookfield is set to acquire a Sydney office for $318M, while Macquarie finalizes an $8.3B Qube deal, and ESR sells Yokohama warehouse stakes amid...

Asia Real Estate Tracker

Singapore Market Roundup (10-Feb-2026): OCBC raises Boustead Singapore's fair value to $2.45.

OCBC raises Boustead Singapore's fair value to $2.45; DBS and RHB maintain 'buy' on Elite UK REIT; OCBC lowers Sheng Siong to 'hold' but raises...

Singapore Market Roundup

Singapore Market Roundup (30-Jan-2026): CSE Global rated 'buy' by Beansprout, target $1.40.

Beansprout rates CSE Global 'buy' at $1.40. DBS lifts Nam Cheong to $1.60, labeling it a 'hidden gem.' CGSI keeps 'add' on Genting SG for earnings...

Singapore Market Roundup

Singapore Market Roundup (23-Jan-2026): Seatrium endures 'arbitration noise' but CGSI and Citi

Seatrium encounters arbitration issues, but CGSI and Citi remain optimistic. RHB keeps 'buy' on Raffles Medical, while CGSI sees re-rating...

Singapore Market Roundup

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

How Corporate Actions Are Unlocking Mid-Cap Value in the SGX the iEdge Singapore Next 50 Indices

​iEdge Singapore Next 50 index offers a prime arena to identify companies that could unlock value through governance reforms & asset optimization,...

Manishi Raychaudhuri

Asia Real Estate Tracker (17-Feb-2026): Brookfield nears $318M Sydney office deal.

Brookfield is set to acquire a Sydney office for $318M, while Macquarie finalizes an $8.3B Qube deal, and ESR sells Yokohama warehouse stakes amid...

Asia Real Estate Tracker

Singapore Market Roundup (10-Feb-2026): OCBC raises Boustead Singapore's fair value to $2.45.

OCBC raises Boustead Singapore's fair value to $2.45; DBS and RHB maintain 'buy' on Elite UK REIT; OCBC lowers Sheng Siong to 'hold' but raises...

Singapore Market Roundup

Singapore Market Roundup (30-Jan-2026): CSE Global rated 'buy' by Beansprout, target $1.40.

Beansprout rates CSE Global 'buy' at $1.40. DBS lifts Nam Cheong to $1.60, labeling it a 'hidden gem.' CGSI keeps 'add' on Genting SG for earnings...

Singapore Market Roundup

Singapore Market Roundup (23-Jan-2026): Seatrium endures 'arbitration noise' but CGSI and Citi

Seatrium encounters arbitration issues, but CGSI and Citi remain optimistic. RHB keeps 'buy' on Raffles Medical, while CGSI sees re-rating...

Singapore Market Roundup

iEdge Singapore Next 50 index offers a prime arena to identify companies that could unlock value through governance reforms & asset optimization,...